Joseph D. Rosenblatt
- Immunology top 0.2%
- T-cell and Retrovirus Studies 50
- Immunotherapy and Immune Responses 22
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 59
- Agronomy and Crop Science top 0.2%
- Animal Disease Management and Epidemiology 40
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 19
- Oncology top 0.5%
- CAR-T cell therapy research 24
-
- Vector-Borne Animal Diseases 37
-
- Monoclonal and Polyclonal Antibodies Research 27
- Co-authors
- David ParryTerence A. PartridgeIrvin S. Y. ChenNancy L. BartlettDana A. KennedyEric L. SieversJoseph M. ConnorsAnas Younes
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Joseph D. Rosenblatt
222 papers receiving 12.3k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Immunology 4.6k
- Pathology and Forensic Medicine 3.2k
- Agronomy and Crop Science 1.6k
- Genetics 1.6k
- Oncology 3.9k
Countries citing papers authored by Joseph D. Rosenblatt
This map shows the geographic impact of Joseph D. Rosenblatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph D. Rosenblatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph D. Rosenblatt more than expected).
Fields of papers citing papers by Joseph D. Rosenblatt
This network shows the impact of papers produced by Joseph D. Rosenblatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph D. Rosenblatt. The network helps show where Joseph D. Rosenblatt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joseph D. Rosenblatt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2019 | 26 | |
| 3 | 2018 | 2 | |
| 4 | 2012 | 34 | |
| 5 | Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphomabreakdown → | 2012 | 1014 |
| 6 | 2012 | 411 | |
| 7 | 2011 | 160 | |
| 8 | 2009 | 33 | |
| 9 | 2009 | 10 | |
| 10 | 2007 | 17 | |
| 11 | Phase I trial of glycolitic inhibition with 2-deoxyglucose and docetaxel for patients with solid tumors | 2006 | 4 |
| 12 | 2005 | 3 | |
| 13 | Preliminary analysis of the pilot study using gabapentin on tamoxifen-induced hot flashes in women with breast cancer | 2001 | 2 |
| 14 | 1999 | 87 | |
| 15 | In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice. | 1999 | 45 |
| 16 | 1998 | 25 | |
| 17 | 1998 | 4 | |
| 18 | 1994 | 82 | |
| 19 | 1990 | 9 | |
| 20 | 1978 | 3 |
About Joseph D. Rosenblatt
Joseph D. Rosenblatt is a scholar working on Immunology, Agronomy and Crop Science and Pathology and Forensic Medicine, having authored 226 papers that have together received 12.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (59 papers), T-cell and Retrovirus Studies (50 papers), Animal Disease Management and Epidemiology (40 papers), Vector-Borne Animal Diseases (37 papers), Monoclonal and Polyclonal Antibodies Research (27 papers), CAR-T cell therapy research (24 papers), Immunotherapy and Immune Responses (22 papers) and Chronic Lymphocytic Leukemia Research (19 papers). The work is most often cited by research in Immunology (4.6k citations), Pathology and Forensic Medicine (3.2k citations) and Agronomy and Crop Science (1.6k citations). Joseph D. Rosenblatt has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include David Parry, Terence A. Partridge, Irvin S. Y. Chen, Nancy L. Bartlett, Dana A. Kennedy, Eric L. Sievers, Joseph M. Connors, Anas Younes, Andres Forero‐Torres and Radhakrishnan Ramchandren. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Virology, Cancer Research and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.